Connect Biopharma Holdings Ltd (CNTB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 9M 18M 27M Q2 '24: 24.1M Q3 '24: 1.2M Q4 '24: 698K Q1 '25: 0 Q2 '25: 48K Q3 '25: 16K Q4 '25: 0 Q1 '26: 169K Q2 '26: 2.8M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-21M -14M -7M 0 7M 14M 21M Q1 '24: -12.6M Q2 '24: 13.6M Q3 '24: -13.8M Q4 '24: -9.6M Q1 '25: -11.4M Q2 '25: -13.4M Q3 '25: -17.7M Q4 '25: -15.5M Q1 '26: -19.6M Q2 '26: -17.6M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Net Income Quarterly

-21M -14M -7M 0 7M 14M 21M Q1 '24: -8.7M Q2 '24: 14.8M Q3 '24: -12.9M Q4 '24: -8.9M Q1 '25: -10.3M Q2 '25: -12.9M Q3 '25: -17.2M Q4 '25: -15.1M Q1 '26: -19.4M Q2 '26: -17.3M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-18M -12M -6M 0 6M 12M 18M Q1 '24: -591K Q2 '24: -7.7M Q3 '24: -13M Q4 '24: -2.3M Q1 '25: -10M Q2 '25: -12.6M Q3 '25: -17.4M Q4 '25: -11.2M Q1 '26: -16M Q2 '26: -15.9M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Free Cash Flow Quarterly

-18M -12M -6M 0 6M 12M 18M Q1 '24: -591K Q2 '24: -8M Q3 '24: -13.2M Q4 '24: -2.6M Q1 '25: -10M Q2 '25: -12.9M Q3 '25: -17.4M Q4 '25: -11.3M Q1 '26: -16M Q2 '26: -15.9M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q1 '24: 55.1M Q2 '24: 55.7M Q3 '24: 55.3M Q1 '25: 55.4M Q2 '25: 55.5M Q3 '25: 55.7M Q1 '26: 56.5M Q2 '26: 62.9M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Q4 '24: -0.28 Q1 '25: -0.31 Q2 '25: -0.81 Q3 '25: -0.89 Q4 '25: -1.00 Q1 '26: -1.15 Q2 '26: -1.19 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.